Nifty
:
13188.95
Sensex
:
44812.29
55.05 (0.42%)
179.64 (0.40%)
Nifty
Sensex
:
:
13188.95
44812.29
55.05 (0.42%)
179.64 (0.40%)

Jubilant Life Sciences Ltd.

Chemicals

Rating :
66/99

BSE: 530019 | NSE: JUBILANT

NSE BSE
798.10
03-Dec-2020
  • Open
  • High
  • Low
  • Previous Close
  •  794.00
  •  834.50
  •  791.00
  •  787.90
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1224753
  •  9919.65
  •  909.00
  •  234.35

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 12,676.39
  • 16.34
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 15,904.73
  • 0.63%
  • 2.12

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.68%
  • 3.51%
  • 16.18%
  • FII
  • DII
  • Others
  • 26.05%
  • 0.77%
  • 2.81%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.26
  • 9.75
  • 6.79

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.17
  • 9.32
  • 5.10

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.61
  • 18.05
  • 11.80

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.54
  • 15.36
  • 14.61

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.92
  • 2.42
  • 2.23

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.34
  • 8.86
  • 8.15

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
2,374.89
2,265.93
4.81%
1,892.92
2,181.86
-13.24%
2,391.41
2,385.58
0.24%
2,315.21
2,377.10
-2.60%
Expenses
1,888.71
1,797.48
5.08%
1,590.70
1,747.26
-8.96%
1,854.80
2,027.61
-8.52%
1,807.79
1,883.84
-4.04%
EBITDA
486.18
468.45
3.78%
302.22
434.60
-30.46%
536.61
357.97
49.90%
507.42
493.26
2.87%
EBIDTM
20.47%
20.67%
15.97%
19.92%
14.01%
14.01%
21.92%
20.75%
Other Income
7.28
12.26
-40.62%
8.13
9.70
-16.19%
19.44
-6.58
-
6.03
29.02
-79.22%
Interest
63.95
71.64
-10.73%
75.95
72.58
4.64%
71.16
61.59
15.54%
72.03
53.13
35.57%
Depreciation
115.84
116.84
-0.86%
112.30
102.69
9.36%
128.94
95.02
35.70%
113.46
98.40
15.30%
PBT
313.67
292.23
7.34%
122.10
269.03
-54.61%
355.95
-39.98
-
293.32
355.61
-17.52%
Tax
89.55
42.84
109.03%
34.09
84.05
-59.44%
95.46
60.67
57.34%
89.94
88.09
2.10%
PAT
224.12
249.39
-10.13%
88.01
184.98
-52.42%
260.49
-100.65
-
203.38
267.52
-23.98%
PATM
9.44%
11.01%
4.65%
8.48%
7.11%
7.11%
8.78%
11.25%
EPS
14.07
15.66
-10.15%
5.52
11.61
-52.45%
16.35
-6.32
-
12.77
16.79
-23.94%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
8,974.43
9,154.41
9,110.82
7,517.84
5,861.43
5,749.13
5,826.25
5,803.36
5,165.95
4,303.13
3,445.62
Net Sales Growth
-2.56%
0.48%
21.19%
28.26%
1.95%
-1.32%
0.39%
12.34%
20.05%
24.89%
 
Cost Of Goods Sold
6,887.62
3,140.58
3,521.84
2,862.51
2,002.74
2,116.20
2,663.02
2,438.46
2,062.85
1,618.87
1,339.68
Gross Profit
2,086.81
6,013.84
5,588.98
4,655.33
3,858.69
3,632.94
3,163.23
3,364.90
3,103.10
2,684.26
2,105.95
GP Margin
23.25%
65.69%
61.34%
61.92%
65.83%
63.19%
54.29%
57.98%
60.07%
62.38%
61.12%
Total Expenditure
7,142.00
7,207.34
7,371.81
5,999.45
4,516.14
4,502.19
5,124.71
4,782.37
4,097.81
3,412.94
2,880.76
Power & Fuel Cost
-
473.80
466.38
424.91
333.66
366.71
393.04
389.74
356.73
286.89
224.04
% Of Sales
-
5.18%
5.12%
5.65%
5.69%
6.38%
6.75%
6.72%
6.91%
6.67%
6.50%
Employee Cost
-
2,127.68
1,925.96
1,555.88
1,230.93
1,125.09
1,090.28
1,105.17
962.58
836.36
718.54
% Of Sales
-
23.24%
21.14%
20.70%
21.00%
19.57%
18.71%
19.04%
18.63%
19.44%
20.85%
Manufacturing Exp.
-
602.62
552.26
485.98
428.84
436.46
432.40
405.14
360.48
329.75
284.66
% Of Sales
-
6.58%
6.06%
6.46%
7.32%
7.59%
7.42%
6.98%
6.98%
7.66%
8.26%
General & Admin Exp.
-
488.39
540.75
354.56
280.98
256.23
302.28
264.23
208.35
200.72
195.72
% Of Sales
-
5.34%
5.94%
4.72%
4.79%
4.46%
5.19%
4.55%
4.03%
4.66%
5.68%
Selling & Distn. Exp.
-
292.70
267.70
247.85
185.79
135.54
203.98
160.04
123.28
111.85
90.92
% Of Sales
-
3.20%
2.94%
3.30%
3.17%
2.36%
3.50%
2.76%
2.39%
2.60%
2.64%
Miscellaneous Exp.
-
81.58
96.92
67.76
53.20
65.96
39.72
19.59
23.53
28.50
90.92
% Of Sales
-
0.89%
1.06%
0.90%
0.91%
1.15%
0.68%
0.34%
0.46%
0.66%
0.79%
EBITDA
1,832.43
1,947.07
1,739.01
1,518.39
1,345.29
1,246.94
701.54
1,020.99
1,068.14
890.19
564.86
EBITDA Margin
20.42%
21.27%
19.09%
20.20%
22.95%
21.69%
12.04%
17.59%
20.68%
20.69%
16.39%
Other Income
40.88
47.43
35.74
40.03
24.86
13.37
42.45
19.06
29.87
31.48
17.24
Interest
283.09
287.41
219.81
284.28
341.11
371.35
367.61
337.11
310.93
238.23
119.99
Depreciation
470.54
461.93
370.90
415.05
291.40
346.74
287.95
281.17
253.79
220.65
180.10
PBT
1,085.04
1,245.17
1,184.04
859.08
737.64
542.22
88.43
421.78
533.29
462.79
282.02
Tax
309.04
312.29
326.80
224.66
163.02
155.40
80.48
69.64
152.36
68.41
13.37
Tax Rate
28.48%
25.80%
36.16%
26.15%
22.10%
28.66%
199.55%
33.60%
44.66%
59.95%
5.56%
PAT
776.00
898.24
574.46
642.81
575.66
391.83
-57.76
109.04
152.73
14.56
229.72
PAT before Minority Interest
775.91
898.24
577.01
634.42
574.63
386.82
-40.16
137.64
188.78
45.69
227.23
Minority Interest
-0.09
0.00
-2.55
8.39
1.03
5.01
-17.60
-28.60
-36.05
-31.13
2.49
PAT Margin
8.65%
9.81%
6.31%
8.55%
9.82%
6.82%
-0.99%
1.88%
2.96%
0.34%
6.67%
PAT Growth
29.07%
56.36%
-10.63%
11.66%
46.92%
-
-
-28.61%
948.97%
-93.66%
 
EPS
48.71
56.39
36.06
40.35
36.14
24.60
-3.63
6.84
9.59
0.91
14.42

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
5,603.88
4,808.92
4,086.53
3,436.04
2,966.26
2,453.52
2,626.51
2,476.12
2,257.03
2,172.27
Share Capital
15.93
15.93
15.58
15.57
15.54
15.93
15.45
15.93
15.93
15.93
Total Reserves
5,587.95
4,792.94
4,070.78
3,419.98
2,950.72
2,437.59
2,611.07
2,460.19
2,241.10
2,156.34
Non-Current Liabilities
4,087.52
4,420.21
3,417.47
3,826.06
3,347.13
4,036.15
2,184.95
3,004.85
3,224.12
3,048.25
Secured Loans
728.92
811.65
729.88
1,581.96
2,620.41
3,316.29
1,716.67
1,708.74
2,839.47
2,435.91
Unsecured Loans
3,010.76
3,431.24
2,317.93
1,923.07
392.79
375.00
0.22
760.06
0.45
400.61
Long Term Provisions
150.75
114.35
107.08
80.69
70.31
67.04
219.53
237.96
169.70
39.87
Current Liabilities
2,619.01
2,089.73
2,004.69
1,684.04
2,464.44
2,129.16
3,894.41
2,778.35
2,212.79
2,269.67
Trade Payables
1,090.27
1,020.13
1,136.16
749.49
612.12
721.19
718.14
647.13
836.98
517.43
Other Current Liabilities
674.21
473.57
505.87
572.70
951.43
793.31
1,731.20
898.00
499.55
465.94
Short Term Borrowings
649.89
499.71
244.85
255.60
748.97
517.17
1,187.83
1,131.39
767.07
883.03
Short Term Provisions
204.64
96.31
117.81
106.24
151.93
97.49
257.25
101.84
109.18
403.28
Total Liabilities
12,310.41
11,318.96
9,457.17
8,898.75
8,739.70
8,618.83
8,863.81
8,370.86
7,762.89
7,532.00
Net Block
6,339.97
5,648.38
5,400.55
5,106.73
5,104.42
4,911.33
5,098.78
4,967.46
4,460.18
3,991.05
Gross Block
7,982.83
6,905.50
6,288.86
5,672.38
5,390.82
7,362.10
7,330.63
6,870.15
6,084.09
5,163.28
Accumulated Depreciation
1,642.85
1,257.12
888.31
565.66
286.40
2,450.76
2,231.85
1,902.69
1,623.92
1,172.22
Non Current Assets
7,272.06
6,734.16
6,267.41
5,950.63
5,864.37
5,904.29
5,935.78
5,809.80
5,465.57
4,940.25
Capital Work in Progress
768.39
901.43
670.97
683.78
611.32
596.60
472.39
436.89
685.55
666.71
Non Current Investment
69.36
115.11
123.52
102.71
85.43
39.50
33.99
25.61
19.20
32.75
Long Term Loans & Adv.
86.81
68.59
71.79
56.32
62.67
327.17
328.42
379.47
299.86
249.18
Other Non Current Assets
7.53
0.66
0.58
1.08
0.53
29.68
2.21
0.37
0.79
0.55
Current Assets
5,038.35
4,584.80
3,189.76
2,948.12
2,875.32
2,714.54
2,928.03
2,561.06
2,297.32
2,591.75
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
1,845.38
1,417.39
1,391.39
1,220.40
1,203.10
1,235.33
1,341.42
1,116.18
1,020.22
691.28
Sundry Debtors
1,293.22
1,271.55
1,130.76
1,005.30
950.50
819.27
805.87
708.54
652.69
520.45
Cash & Bank
1,399.87
1,370.41
248.79
459.63
344.58
394.34
479.53
356.05
266.82
1,045.14
Other Current Assets
499.88
485.64
373.06
225.73
377.13
265.59
301.21
380.29
357.59
334.88
Short Term Loans & Adv.
41.33
39.80
45.75
37.06
133.06
144.56
136.04
182.01
256.70
217.50
Net Current Assets
2,419.34
2,495.07
1,185.06
1,264.08
410.88
585.38
-966.38
-217.29
84.53
322.08
Total Assets
12,310.41
11,318.96
9,457.17
8,898.75
8,739.69
8,618.83
8,863.81
8,370.86
7,762.89
7,532.00

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
1,542.94
1,121.51
1,303.20
1,268.49
1,098.89
783.26
772.27
969.90
707.17
389.75
PBT
1,210.53
903.81
859.08
737.64
542.22
40.32
207.28
341.14
114.11
240.59
Adjustment
760.74
861.53
687.81
637.90
737.89
725.84
756.60
752.36
795.44
318.42
Changes in Working Capital
-179.67
-300.53
14.15
36.88
-133.16
96.40
-110.70
-4.04
-136.91
-84.14
Cash after chg. in Working capital
1,791.60
1,464.82
1,561.04
1,412.42
1,146.96
862.57
853.18
1,089.46
772.64
474.88
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-248.66
-343.31
-257.84
-143.94
-48.07
-79.31
-80.91
-119.56
-65.47
-85.14
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-327.00
-1,011.84
-617.70
-450.39
-312.53
-343.33
-174.42
-499.72
-594.31
-352.15
Net Fixed Assets
-241.66
-305.67
-147.58
-115.33
785.60
1,162.43
-166.96
-286.05
-434.15
-275.33
Net Investments
-0.14
-57.59
3.34
-0.39
57.01
239.81
-27.56
-18.79
-95.66
5.14
Others
-85.20
-648.58
-473.46
-334.67
-1,155.14
-1,745.57
20.10
-194.88
-64.50
-81.96
Cash from Financing Activity
-1,050.37
657.43
-901.13
-685.87
-842.75
-502.69
-414.41
-449.76
-888.82
608.21
Net Cash Inflow / Outflow
165.56
767.10
-215.63
132.22
-56.38
-62.76
183.44
20.41
-775.95
645.81
Opening Cash & Equivalents
1,005.40
244.18
456.44
339.27
391.64
473.49
279.65
263.08
1,041.15
498.27
Closing Cash & Equivalent
1,230.81
1,005.40
244.18
456.44
339.27
391.63
473.49
279.65
263.08
1,041.15

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
351.83
301.93
262.33
220.61
190.90
154.04
170.07
155.46
141.70
136.38
ROA
7.60%
5.55%
6.91%
6.52%
4.46%
-0.46%
1.60%
2.34%
0.60%
3.17%
ROE
17.25%
12.97%
16.87%
17.95%
14.27%
-1.58%
5.39%
7.98%
2.06%
10.42%
ROCE
15.07%
13.06%
15.21%
14.44%
12.42%
5.72%
7.92%
10.19%
5.79%
6.29%
Fixed Asset Turnover
1.23
1.38
1.26
1.09
0.92
0.81
0.84
0.82
0.78
0.70
Receivable days
51.13
48.12
51.58
59.43
54.81
49.56
46.53
47.00
48.71
53.83
Inventory Days
65.05
56.26
63.07
73.64
75.51
78.58
75.51
73.76
71.07
71.61
Payable days
53.01
55.42
56.86
54.84
53.44
52.17
51.42
45.33
38.70
50.95
Cash Conversion Cycle
63.17
48.96
57.79
78.23
76.88
75.98
70.61
75.42
81.08
74.50
Total Debt/Equity
0.83
1.01
0.85
1.18
1.51
1.95
1.67
1.71
1.69
1.81
Interest Cover
5.21
5.11
4.02
3.16
2.46
1.11
1.61
2.10
1.48
3.01

Annual Reports:

FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013
FY 2012
FY 2011

News Update:


  • Jubilant Life Sciences issues CPs of Rs 90 crore
    26th Nov 2020, 14:55 PM

    The aggregate amount of Commercial Papers (including this issue) outstanding as on date is Rs 90 crore

    Read More
  • Jubilant Life Sciences gets nod to raise Rs 100 crore via NCDs
    5th Nov 2020, 10:18 AM

    The Board of Directors of the company, at its meeting held on November 4, 2020 has approved the same

    Read More
  • Jubilant Life Sciences raises Rs 90 crore via Commercial Papers
    12th Oct 2020, 15:47 PM

    Date of maturity of the said commercial papers is November 26, 2020

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.